Suzanne Ildstad, Director at Talaris Therapeutics, Inc. (TALS), sold 44,020 shares at $2.59 ($112K) on 2023-06-12, disclosed to the SEC on 2023-06-14.
Open-market sale of $112k TALS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.59 | 16,870 | $44K | 38.9% |
| 2 | $2.56 | 14,208 | $36K | 32.4% |
| 3 | $2.49 | 12,942 | $32K | 28.7% |
| Total | $2.55 avg | 44,020 | $112K | 100% |
| Filing → |
| TALS | SELL | 2023-06-05 | $80K | — | Filing → |
| TALS | SELL | 2023-04-25 | $35K | — | Filing → |
| TALS | SELL | 2023-04-21 | $266K | — | Filing → |